ReviewWorld journal of radiology2026
Radiolabeled exosomes for theranostics: Personalized tailored therapy through imaging.
Review in World journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiolabeled exosomes have emerged as a transformative platform at the intersection of nanomedicine, molecular imaging, and precision theranostics. These nanoscale extracellular vesicles exhibit intrinsic biocompatibility, low immunogenicity, and inherent targeting capabilities, making them highly attractive for both diagnostic and therapeutic applications. The integration of radiochemistry with exosome biology enables noninvasive, real-time tracking of biodistribution, pharmacokinetics, and target engagement using advanced imaging modalities such as positron emission tomography and single-photon emission computed tomography. This minireview comprehensively summarizes current radiolabeling strategies for exosomes, including direct and indirect approaches, highlighting their advantages, limitations, and impact on vesicle integrity and imaging accuracy. Furthermore, we discuss key imaging platforms,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.